Molecular Modelling Market 2018 – Advantage to the Advanced Players

The report titled “Molecular Modelling Market -Forecast to 2023″ is a direct appreciation by Market Research Future of the market potential of the Molecular Modelling Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market! The global molecular modelling market is expected to grow at a CAGR of ~ 15.4 % during the forecast period 2017-2023.

MarketResearchFuture.com adds “Molecular Modelling Market -2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

Global Molecular Modelling Market - Regional Analysis:

The Americas leads Global Molecular Modelling Market due to the presence of the developed countries within the region like the U.S. and Canada which have developed healthcare sector to facilitate the market growth. Europe is the second market for Global Molecular Modelling Market and is followed by the Asia Pacific region. A huge patient population, favourable government policies and increasing precipitate healthcare expenditure drives the market growth within the region. The Middle East & Africa holds the least market share, especially due to the presence of the poor economies within the region.

Major Players in the Molecular Modelling Market:

Fisher Scientific Company LLC. (US), Indigo Instruments (US), Simulation Plus (US), Certara, L.P. (US), Dassault Systèmes (France), Advanced Chemistry Development (Canada), Schrödinger, LLC (US), Genedata AG (Switzerland), Chemical Computing Group ULC (Canada), Physiomics PLC (UK), and Entelos, Inc. (US).are some of the prominent players at the forefront of competition in the Global Molecular Modelling Market and are profiled in MRFR Analysis.

Global Molecular Modelling Market - Competitive Analysis:

Characterized by the presence of several well-established and small players, the global market of molecular modelling market appears to be highly competitive and fragmented. International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing.  The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers. Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

In May-2016, Thermo Fisher Scientific Inc., the world leader in serving science, and FEI Company, the leader in high-performance electron microscopy, announced that their boards of directors have unanimously approved Thermo Fisher’s acquisition of FEI for USD 107.50 per share in cash. The transaction represents a purchase price of approximately USD 4.2 billion.

In June-2017, Simulations Plus, Inc., a leading provider of simulation and modelling software for pharmaceutical discovery and development, announced that the Stock Purchase Agreement with DILIsym Services, Inc. of Research Triangle Park, North Carolina, has been closed, and DILIsym is now a division of Simulations Plus. DILIsym is the global leader in the simulation of drug-induced liver injury.

GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/4330 .

Global Molecular Modelling Market - Overview:

The molecular modelling market is growing with the rapid pace. According to a recent study report published by the Market Research Future, The Global Molecular Modelling Market is booming and expected to gain prominence over the forecast period growing rapidly .The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023).

Molecular modelling is an essential tool in the medicinal chemistry for the drug design process. It involves various paradigms of advanced technology for generation, manipulation as well as representation of three-dimensional structures of molecules and their associated physic-chemical properties. The application areas are inclusive of drug designing, computational biology, computational chemistry, materials science, and others. It involves wide range of computerized techniques based on theoretical chemistry methods and experimental data to analyse the biological and molecular property. Molecular modelling has become a valuable and essential tool in the medicinal chemistry for the drug design process. It describes generation, manipulation or representation of three-dimensional structures of molecules and their associated physic-chemical properties. The method is used in drug design, computational biology, computational chemistry, and materials science. It involves wide range of computerized techniques based on theoretical chemistry methods and experimental data to analyze the biological and molecular property. Increasing of biotechnology and pharmaceutical industries in R&D, increasing prevalence of different diseases, and rising need for the better drug treatments. The U.S. is the largest market for biopharmaceuticals and accounts for one third of the global market. Moreover, it is estimated that the U.S. biopharmaceutical sector accounts around 17% of all domestic R&D funded by the U.S. businesses and added an estimated USD 1.2 trillion in economic output of 2014. Moreover,

• According to the Indian Brand Equity Foundation in 2017, the Indian biotech industry holds about 2% share of the global biotech industry. The biotechnology industry in India, comprises of about 800 companies and is valued to be about USD 11.6 billion in 2017. However, high cost of the research & development may hamper the market growth during the corresponding period.

Segmentation of Global Molecular Modelling Market:

The global molecular modelling market has been segmented on the basis of approach, application, products, and end user.

On the basis of approach, the market is segmented into molecular mechanics approach, and quantum chemistry approach.

On the basis of product, the market is segmented into instruments, reagents, kits, and others.

On the basis of application, the market is segmented into drug development, drug discovery, and other application. The drug discovery is further segmented into direct drug design, indirect drug design, and molecular mimicry. The direct drug design is sub-segmented into lead identification, target identification, and others. The indirect drug design is sub-segmented into pharmacophore, quantitative structure-activity relationships (QSAR), and others.

On the basis of end user, the market is segmented into pharmaceutical & biotechnological companies, research organizations, and others.

…CONTINUED

AVAIL DISCOUNT @ https://www.marketresearchfuture.com/check-discount/4330 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]

Posted by Vivian Dsena on Tuesday January 23 2018, 3:45 PM EST. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0